XTX Topco Ltd - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 118 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$139,093
-7.5%
62,938
-21.7%
0.02%
-21.9%
Q4 2022$150,324
-6.6%
80,387
+28.6%
0.03%
-20.0%
Q3 2022$161,000
+360.0%
62,510
+243.1%
0.04%
+185.7%
Q2 2022$35,000
-66.7%
18,219
-48.4%
0.01%
-69.6%
Q1 2022$105,000
-11.8%
35,324
+33.6%
0.05%
-31.3%
Q4 2021$119,000
+65.3%
26,449
+77.3%
0.07%
+179.2%
Q3 2021$72,000
-33.9%
14,917
-3.3%
0.02%
-54.7%
Q1 2021$109,00015,4250.05%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders